Practice Therapeutics New oral anticoagulants for thromboprophylaxis in patients having hip or knee arthroplasty BMJ 2011; 342 doi: https://doi.org/10.1136/bmj.c7270 (Published 18 January 2011) Cite this as: BMJ 2011;342:c7270 Article Related content Metrics Responses Peer review Related articles Editorial The new BMJ series on therapeutics Published: 18 January 2011; BMJ 342 doi:10.1136/bmj.d37 See more Cardiovascular disease: Just one in 12 eligible people had health check last year, watchdog finds BMJ November 13, 2024, 387 q2518; DOI: https://doi.org/10.1136/bmj.q2518 Semaglutide’s CVD indication could cost US Medicare $145bn extra a year BMJ August 28, 2024, 386 q1878; DOI: https://doi.org/10.1136/bmj.q1878 Semaglutide: UK regulator approves drug for prevention of cardiovascular events BMJ July 25, 2024, 386 q1660; DOI: https://doi.org/10.1136/bmj.q1660 Why India is failing to track heatstroke fatalities properly BMJ July 17, 2024, 386 q1437; DOI: https://doi.org/10.1136/bmj.q1437 Mail on Sunday articles that accused three commentators of being “statin deniers” were misinformed, judge rules BMJ June 26, 2024, 385 q1424; DOI: https://doi.org/10.1136/bmj.q1424 Cited by... The new BMJ series on therapeuticsFulltext
